Nanotechnology Now - News Story: Merck Corporate Symposium To Be Held Exclusively at NSTI Nanotech 2008-Boston

Home > News > Merck Corporate Symposium To Be Held Exclusively at NSTI Nanotech 2008-Boston

October 22nd, 2007

Merck Corporate Symposium To Be Held Exclusively at NSTI Nanotech 2008-Boston

Abstract:
The Nano Science and Technology Institute (NSTI) is pleased to announce that abstracts are being accepted for the Merck Corporate Symposium: Targeted Delivery of siRNA, to be held during Nanotech 2008 in Boston, MA. The Symposium will provide an important platform for Merck to engage leading researchers in the nano tech community and create a discussion around the application of emerging nano technologies and their ability to affect targeted delivery of therapeutic siRNA molecules.
Merck places a strong emphasis on innovation in all areas of drug research, development and commercialization. "Merck is pleased to partner with the NSTI in bringing this Symposium to Greater Boston, a leading region for the life sciences industry and advanced patient care," said Dr. Reid Leonard, Merck's Executive Director of Licensing and External Research. "Nanotech 2008 reflects our commitment to innovation and provides an ideal forum for the presentation of siRNA enabling technologies - an area where Merck has assumed a leadership role."

To participate in the Merck Corporate Symposium, please submit your abstract through the Nanotech On-Line Abstract Submission form by December 6th, 2007: http://www.nsti.org/Nanotech2008/symposia/Merck.html

Source:
nsti.org

Bookmark: